The rand gave back all of Monday’s gains on Tuesday as the euphoria over a possible coronavirus vaccine faded, with investors now cautious about the details regarding its preparation and distribution.

On Monday, news emerged that a vaccine developed by US pharmaceutical giant Pfizer in partnership with BioNTech was showing good results in the testing phase. ..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now